Substrate Artificial Intelligence's (OTCQB:SUIAF) prelims revealed a business growing rapidly and making progress across all divisions, said research house Edison, which provided an upbeat assessment of the group's performance and prospects.
While Substrate results were boosted by full-year contributions from acquisitions made in prior periods, the company reported growth across all its business divisions: health, human resources, agritech, and edtech.
Edison highlighted that the health division’s performance was driven by a major public sector contract, while the human resources segment benefited from increased project work with existing clients.
Listed on BME Growth since May 2022, the company operates as a holding entity for businesses leveraging AI to drive efficiencies in sectors such as health, agritech and HR.
The company’s gross revenues rose 75% year-on-year to €24.2 million, with earnings before interest, tax, depreciation and amortisation (EBITDA) reaching €4.9 million, up from a €1.9m loss in 2023.
Looking ahead, Substrate's prospects will be augmented by projects such as the announcement of the €100 million ‘AI City’ project in Talavera de la Reina.
This infrastructure investment is expected to enhance Substrate AI’s internal capabilities, particularly in healthcare R&D, while also providing AI solutions to third-party businesses.
Edison also pointed to the 2024 release of Substrate AI’s Serenity Star AI solution and emphasised the importance of 2025 as the company shifts focus towards turnkey AI solutions alongside its existing acquisition and start-up investments.
With growth across sectors and a clear strategy for infrastructure and product innovation, Substrate AI is positioning itself as a key player in the European AI landscape.